Pricing Log in Create free account
Friday 6 November 2026 Export AMRX’s income statement to Excel — free account

AMNEAL PHARMACEUTICALS, INC.

AMRX Healthcare Drug Manufacturers Specialty & Generic

AMNEAL PHARMACEUTICALS, INC.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, up 8.05% from fiscal 2024.

Revenue
+9.96%
EPS
+267.0%
Free cash flow
−50.9%
Total debt
+23.8%

Quarter to September 2026, against a year earlier

19.80 0.35 +1.80%
Market cap
$6.8B
P/E
36.9×
Fwd P/E
44.2×
Dividend yield
—
F-score
7/9
Altman Z
1.94
Beneish M
−2.68
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

AMNEAL PHARMACEUTICALS, INC. (AMRX) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, AMNEAL PHARMACEUTICALS, INC. (AMRX) trades at a P/S ratio of 2.0×. Over the past ten years it has ranged from 0.1× (March 2023) to 2.4× (August 2018); the current reading is higher than 97% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 2.1× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 1.3× 49.33%
FY2024 0.9× 99.07%
FY2023 0.4× 205.56%
FY2022 0.1× (57.73%)
FY2021 0.3× 0.74%
FY2020 0.3× (13.61%)
FY2019 0.4× (62.18%)
FY2018 1.0× 8.33%
FY2017 1.0× 0.00%
FY2016 1.0× 0.00%

Quarterly newest first

Period P/S ratio Change
Sep 2026 2.1× 19.39%
Jun 2026 1.8× 37.42%
Mar 2026 1.3× (1.40%)
Dec 2025 1.3× 22.07%
43 more quarters

Against its own ten years

Low 0.1× High 2.4×
Ten-year median 0.4×
Current reading's percentile 97

P/S ratio against peers

Company P/S ratio
AMRX AMNEAL PHARMACEUTICALS, INC. 2.0×
HIMS Hims & Hers Health, Inc. compare 2.2×
ELAN Elanco Animal Health Incorporated compare 2.4×
SUPN Indivior Pharmaceuticals Inc. compare 2.4×
RDY Dr. Reddy's Laboratories Ltd compare 3.6×
LNTH Lantheus Holdings, Inc. compare 4.2×
ALKS Alkermes plc compare 4.3×
KNSA Kiniksa Pharmaceuticals International, plc compare 7.3×
LQDA Liquidia Corporation compare 8.8×
Drug Manufacturers Specialty & Generic industry median 2.1×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on AMRX